Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer
2+ day, 14+ hour ago (836+ words) CAR T-cells developed at CU Anschutz will target two pathways that help colorectal tumors grow and evade the immune system AURORA, Colo., Sept. 10, 2026 /PRNewswire/ -- The U.S. Food and Drug Administration has granted permission for investigators at the University of Colorado Anschutz…...
Latest Update with Dr Salla
2+ hour, 42+ min ago (121+ words) The video "Latest Update with Dr Salla" touches upon several recurring themes central to his work. While specific details would emerge from viewing the video, his typical analyses often converge around a few core pillars: "The emergence of a breakaway…...
Truth about blood cancer remission: Why relapse happens and how to monitor it?
22+ hour, 57+ min ago (65+ words) Even when patients are told that they are in total remission, in some cases, there are chances of a relapse. However, it doesn't imply all patients may suffer a relapse. Frequent monitoring and early reporting of any unusual symptoms can…...
Immune Side Effects May Signal Stronger Tumor Shrinkage and Longer Survival
45+ min ago (628+ words) When patients with advanced gastric cancer receive immune checkpoint inhibitors, one of the most puzzling phenomena in modern oncology is the apparent paradox that side effects can be good news....
Why cancer affects children differently to adults
2+ day, 14+ hour ago (723+ words) When a family receives the devastating news that their child has cancer, one of the first questions they usually ask is “How is that possible, they’re just a child?” The first thing to bear in mind is that there is…...
Dual PI3K/mTOR Inhibitor VDC597 Shows Promise Against Canine Lymphoma and
1+ hour, 28+ min ago (732+ words) Lymphoma is one of the most common diagnoses in veterinary oncology, accounting for roughly 7 to 24 percent of all canine cancers and fully 80 percent of hematopoietic tumors in dogs....
Expressive Writing Helps Rural Breast Cancer Survivors Find Strength After
1+ hour, 28+ min ago (75+ words) For women living far from hospitals and support groups, a cancer diagnosis can feel like an isolation sentence stacked on top of a medical one. New research suggests that something as simple as writing about their deepest thoughts and feelings…...
Cancer Drug Hand-Foot Syndrome Risks Mapped in Huge FDA Analysis
1+ hour, 40+ min ago (55+ words) A painful, red, blistering rash on the palms and soles is one of the most common reasons cancer patients quietly suffer through their treatment, and a new analysis of more than two decades of American drug-safety reports is now offering…...
PROTACs Move From Lab Concept to Clinical Reality in Targeted Protein
1+ hour, 42+ min ago (746+ words) A sweeping new review published in Discover Chemistry charts the remarkable rise of proteolysis-targeting chimeras, better known as PROTACs, from a bold theoretical idea to one of the most closely watched platforms in modern drug discovery. Written by Sandip G....
ATR Inhibitor Ceralasertib Restores Trifluridine’s Power Against
1+ hour, 56+ min ago (680+ words) Colorectal cancer remains one of the deadliest malignancies worldwide, responsible for roughly 0.94 million deaths in 2020 and nearly 1.93 million new cases, according to the International Agency for Research on Cancer....